Rethinking Cancer

Organisers: Ross Cagan

Date: 20th - 23rd November 2016

Location: Wiston House, Steyning, West Sussex, UK

Cancer therapeutics currently have the lowest clinical trial success rate of all major diseases. Partly as a result, cancer will soon be the leading cause of mortality in developed countries. As a disease embedded in the fundamentals of our biology, it presents difficult challenges that would benefit from uniting a variety of related and unrelated fields. Combining extant cancer approaches with input from experts in engineering, mathematics, computational biology, Wall Street and Insurance company economic modellers, entrepreneurs, and smart thinkers from, for example, the arts would help rethink a challenging health problem, including cancer prevention and diagnosis, and the development of therapeutics to stop disease progression and prolong patient lives. The topics that were discussed included big data versus small data, engineering solutions (in therapeutics and detection), mixing approaches, mathematics of cancer, population biology of cancer, risk management and improving clinical trial success. Lymph node metastases in SC+ORT mice

Lymph node metastases in SC+ORT mice

Image credit: Ramon Mangues, Hospital de Sant Pau, Barcelona

Download programme for this Workshop

Organisers & Speakers

Ross Cagan The Mount Sinai Hospital, USA

Fran Balkwill Barts Cancer Institute, UK
Sarah Bohndiek University of Cambridge, UK
Kairbaan Hodivala-Dilke  Queen Mary University of London, UK
Clare Isacke The Institute of Cancer Research, UK
Dowdy Jackson  Agensys, USA
Jos Jonkers Netherlands Cancer Institute, The Netherlands
Scott Lowe Memorial Sloan Kettering Cancer Center, USA
Elaine Mardis  Nationwide Children’s Hospital, USA
Pablo Meyer IBM Computational Biology Center, USA
Ramon Parsons  The Mount Sinai Hospital, USA
Elizabeth Patton  MRC/Cancer Research, UK
Stefano Piccolo  University of Padova, Italy
David Piwnica-Worms MD Anderson Cancer Center, USA
Prem Premsrirut Mirimus, Inc, USA
Victoria Richon  Ribon Therapeutics, Inc., USA
Ben Simons University of Cambridge, UK
Tin Tin Su University of Colorado, USA
Roman Thomas  University of Cologne, Germany

Workshop Photos

This slideshow requires JavaScript.

Rethinking Cancer

20 – 23 November 2016

Wiston House, Steyning, West Sussex, UK

About our Workshops

The Company of Biologists is widely known for its excellence in scientific publishing and it now runs a successful high level series of Workshops. The Workshops provide leading experts and early career scientists from a diverse range of scientific backgrounds with a stimulating environment for the cross fertilization of interdisciplinary ideas. The programmes are carefully developed and are intended to champion the novel techniques and innovations that will underpin important scientific advances.

About our Workshops

About our Journal Meetings

The teams behind our journals bring you the most relevant and challenging topics for discussion through a series of international meetings.

Important meetings serving the communities around our journals.

Each meeting is individually crafted to suit the topic and audience, ranging from small intimate meetings with a focus on intense and detailed discussion to larger meetings with a focus on networking and opportunities for attendees to more widely share their latest research.

Themes explored in the Journal Meetings go on to be discussed in the Company’s journals, helping to shape the field and even the journals themselves.

Propose a new Workshop

If you have a vision for such a meeting but don’t have the time to arrange the logistics or raise the funding, then please contact us. We are seeking proposals for future Workshops and provide all necessary support.

Propose a new Workshop